India to Germany: Gliclazide Export Trade Route

The India to Germany Gliclazide corridor is one of India's established pharmaceutical export routes, with 124 shipments documented worth a combined $4.0M USD. The route is dominated by LUPIN LIMITED, which alone accounts for roughly 64% of all export value, reflecting the consolidated nature of India's gliclazide manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $32.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with gliclazide's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 26.5%, placing it at rank #10 among India's top gliclazide export destinations globally.

On the import side, key buyers of Indian gliclazide in Germany include FIEGE HEALTHCARE LOGISTICS GMBH, SALUTAS PHARMA GMBH- , SALUTAS PHARMA GMBH and 13 others. FIEGE HEALTHCARE LOGISTICS GMBH is the single largest importer with 61 shipments valued at $2.2M USD.

India's gliclazide exports to Germany are driven primarily by a handful of large-scale manufacturers. LUPIN LIMITED with 69 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Germany benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — LUPIN LIMITED, LUPIN LIMITED , IPCA LABORATORIES LIMITED — together account for 94% of total trade value on this route. The average shipment value of $32.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as gliclazide sandoz 30mg 30 nl gliclazide modified release tablets others-medicine put up for retail sale and gliclazide sandoz 30mg 30 nl gliclazidemodified release tablets others-medicine put up for retail sale, suggesting that buyers in Germany tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, FIEGE HEALTHCARE LOGISTICS GMBH is the largest importer with 61 shipments worth $2.2M USD — representing 55% of all gliclazide imports from India on this route. A total of 16 buyers are active on this corridor.